Actively Recruiting

All Genders
ID06377592

Development and Accuracy Evaluation of Gram Staining Analysis AI

Led by GramEye · Updated on 2024-04-22

18000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are developing and evaluating an AI system designed to analyze Gram-stained specimens from clinical settings. This AI aims to improve the accuracy of Gram staining analysis, which is used in diagnosing bacterial infections. The study is observational and focuses on assessing the AI's performance at different accuracy levels. The study involves collecting Gram-stained specimens without any additional intervention from participants. These specimens are then used to develop and test the AI's ability to accurately analyze blood culture Gram stains. There are no treatment groups or placebo controls since the study is observational. Participants who had a Gram stain test ordered as part of their clinical care provide specimens for this study. Researchers measure the AI's accuracy in analyzing these specimens at both advanced and ordinary levels on the first day of analysis. The study does not involve follow-up treatments or interventions, and participation mainly includes allowing use of existing clinical test specimens. The study is expected to continue until March 2027.

CONDITIONS

Brief Title

Development and Accuracy Evaluation of Gram Staining Analysis AI

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients in whom a Gram stain test was ordered
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - 1 day

Participants provide specimens for development of Gram Stain analysis AI without receiving any intervention.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Osaka University Hospital

Suita, Osaka, Japan, 5650871

Actively Recruiting

Loading map...

Research Team

T

Tatsuya Yamada, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging t...

Bacterial Infections

Actively Recruiting

1 location

A Randomized, Double-Blinded Trial to Evaluate XEMBIFY Plus ...

Hypogammaglobulinemia

Actively Recruiting

62 locations

A Phase III, Observer-blind, Randomized Controlled Trial to ...

Pneumococcal Infections

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here